Recombinant Influenza A Virus Hemagglutinin H7 protein (ab190421)

Overview

  • Product name
    Recombinant Influenza A Virus Hemagglutinin H7 protein
  • Protein length
    Full length protein

Description

  • Nature
    Recombinant
  • Source
    Baculovirus infected Sf9 cells
  • Amino Acid Sequence
    • Molecular weight
      62 kDa
    • Additional sequence information
      From virus strain A/Anhui/1/2013 (H7N9).

Specifications

Our Abpromise guarantee covers the use of ab190421 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Western blot

    Functional Studies

    SDS-PAGE

  • Form
    Liquid
  • Additional notes

    Recombinant hemagglutinin glycoprotein provides a control protein for immunoassays and a tool to enhance Orthomyxovirus research.

  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Store at -80°C.

    Constituent: 99% Tris buffered saline

    Contains 0.01% non-ionic detergent.

General Info

  • Alternative names
    • HA7
    • Hemagglutinin 7
  • Relevance
    Haemagglutinin (HA) is one of two main surface fusion glycoproteins embedded in the envelope of influenza viruses, the other being neuraminidase (NA). There are sixteen known HA subtypes (H1-H16) and nine NA subtypes (N1-N9), which together are used to classify influenza viruses (e.g. H5N1). The antigenic variations in HA and NA enable the virus to evade host antibodies made to previous influenza strains, accounting for recurrent influenza epidemics.

Images

  • Hemagglutination with turkey red blood cells: Hemagglutinin Titer 1:2048

  • SDS-PAGE analysis of 0.4 µg ab190421 under reducing conditions.

    The theoretical molecular weight of the protein is ~62 kDa, without glycosylation. Because of the highly glycosylated nature of this protein, migration in an SDS-PAGE gel is slowed resulting in broad, diffuse bands representing differing glycosylation forms.

  • Anti-H7 NY mouse antiserum at 1/100 dilution + Recombinant Influenza A Virus Hemagglutinin H7 protein (ab190421) at 0.38 µg

    Secondary
    Anti-mouse AP conjugate

    Quality control testing demonstrates strong detection of GP null under reduced conditions when using anti-H7 influenza antiserum.

References

ab190421 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab190421.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up